Leerink Partners initiates coverage of Q32 Bio with outperform rating; target price $40
QTTB•Leerink Partners initiated coverage of Q32 Bio with an outperform rating and a $40 target price.
Related News
Wells Fargo cuts Axis Capital Holdings target price to $112 from $126
AXS•
Ategrity Specialty Insurance Company Holdings: Wells Fargo raises target price to $31 from $30
ASIC•
NioCorp Elk Creek mine site to host US energy secretary, EXIM chair and Nebraska officials
NB•
Wells Fargo raises Reinsurance Group of America's target price to $292 from $291
RGA•
Lancashire Holdings: Jefferies raises target price to 691p from 667p
LRE•